T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- PMID: 40216155
- PMCID: PMC12353163
- DOI: 10.1016/j.jid.2025.03.033
T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
Abstract
T cells and structural cells coordinate appropriate inflammatory responses and restoration of barrier integrity following insult. Dysfunctional T cells precipitate skin pathology occurring alongside altered structural cell frequencies and transcriptional states, but to what extent different T cells promote disease-associated changes remains unclear. We show that functionally diverse circulating and skin-resident CD4+CLA+ T-cell populations promote distinct transcriptional outcomes in human keratinocytes and fibroblasts associated with inflamed or healthy tissue. We identify T helper 17 cell-induced genes in keratinocytes that are enriched in psoriasis patient skin and normalized by anti-IL-17 therapy. We also describe a CD103+ skin-resident T-cell-induced transcriptional module enriched in healthy controls that is diminished during psoriasis and scleroderma and show that CD103+ T-cell frequencies are altered during disease. Interrogating clinical data using immune-dependent transcriptional signatures defines the T-cell subsets and genes distinguishing inflamed from healthy skin and allows investigation of heterogeneous patient responses to biologic therapy.
Keywords: Atopic dermatitis; CD4 T cells; Psoriasis; Scleroderma; Skin inflammation.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors declare no competing interests.
Update of
-
T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.bioRxiv [Preprint]. 2024 Dec 22:2024.07.31.606077. doi: 10.1101/2024.07.31.606077. bioRxiv. 2024. Update in: J Invest Dermatol. 2025 Nov;145(11):2811-2827.e8. doi: 10.1016/j.jid.2025.03.033. PMID: 39131334 Free PMC article. Updated. Preprint.
References
-
- Aboobacker S, Kurn H, Al Aboud AM. Secukinumab. StatPearls, Treasure Island (FL): StatPearls Publishing; 2024. - PubMed
-
- Ågren MS, Chafranska L, Eriksen JO, Forman JL, Bjerrum MJ, Schjerling P, et al. Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: A randomised double-blind trial. Eur J Cell Biol 2021;100:151147. 10.1016/j.ejcb.2020.151147. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
